Osteoporotic hip fracture prediction from risk factors available in administrative claims data - A machine learning approach.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 30 09 2019
accepted: 25 04 2020
entrez: 20 5 2020
pubmed: 20 5 2020
medline: 4 8 2020
Statut: epublish

Résumé

Hip fractures are among the most frequently occurring fragility fractures in older adults, associated with a loss of quality of life, high mortality, and high use of healthcare resources. The aim was to apply the superlearner method to predict osteoporotic hip fractures using administrative claims data and to compare its performance to established methods. We devided claims data of 288,086 individuals aged 65 years and older without care level into a training (80%) and a validation set (20%). Subsequently, we trained a superlearner algorithm that considered both regression and machine learning algorithms (e.g., support vector machines, RUSBoost) on a large set of clinical risk factors. Mean squared error and measures of discrimination and calibration were employed to assess prediction performance. All algorithms used in the analysis showed similar performance with an AUC ranging from 0.66 to 0.72 in the training and 0.65 to 0.70 in the validation set. Superlearner showed good discrimination in the training set but poorer discrimination and calibration in the validation set. The superlearner achieved similar predictive performance compared to the individual algorithms included. Nevertheless, in the presence of non-linearity and complex interactions, this method might be a flexible alternative to be considered for risk prediction in large datasets.

Identifiants

pubmed: 32428007
doi: 10.1371/journal.pone.0232969
pii: PONE-D-19-26721
pmc: PMC7237034
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232969

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2017 Apr 10;12(4):e0175383
pubmed: 28394905
Gesundheitswesen. 2009 Dec;71(12):823-31
pubmed: 19387933
BMJ. 2012 May 22;344:e3427
pubmed: 22619194
J Clin Epidemiol. 2004 Feb;57(2):131-41
pubmed: 15125622
Am J Epidemiol. 1997 May 1;145(9):786-93
pubmed: 9143208
Stat Appl Genet Mol Biol. 2007;6:Article25
pubmed: 17910531
BMJ. 2009 Nov 19;339:b4229
pubmed: 19926696
Eur J Health Econ. 2017 Jun;18(5):533-536
pubmed: 27878393
Osteoporos Int. 2015 Apr;26(4):1341-9
pubmed: 25572044
BMC Med Res Methodol. 2014 Dec 22;14:137
pubmed: 25532820
Osteoporos Int. 2014 Jan;25(1):1-21
pubmed: 23797847
Osteoporos Int. 2008 Apr;19(4):385-97
pubmed: 18292978
N Engl J Med. 1991 May 9;324(19):1326-31
pubmed: 2017229
J Clin Epidemiol. 2019 Jun;110:12-22
pubmed: 30763612
Sci Rep. 2016 May 17;6:26094
pubmed: 27185194
Lancet Respir Med. 2015 Jan;3(1):42-52
pubmed: 25466337
Bone. 2018 May;110:170-176
pubmed: 29421456
Bone. 2013 Sep;56(1):16-22
pubmed: 23669650
Am J Manag Care. 2005 Jul;11(7):449-57
pubmed: 16044982
Health Econ. 2012 Dec;21(12):1427-43
pubmed: 22081484
Bone. 2009 May;44(5):734-43
pubmed: 19195497
Stat Med. 1998 Nov 15;17(21):2501-8
pubmed: 9819841
Neural Comput. 2002 Jan;14(1):21-41
pubmed: 11747533
Arch Intern Med. 2009 Dec 14;169(22):2087-94
pubmed: 20008691
Osteoporos Int. 2012 Sep;23(9):2239-56
pubmed: 22419370
PLoS One. 2018 Jan 18;13(1):e0190610
pubmed: 29346409
PLoS One. 2017 Apr 4;12(4):e0174944
pubmed: 28376093
Osteoporos Int. 1999;9(1):29-37
pubmed: 10367027
Calcif Tissue Int. 2017 Apr;100(4):348-360
pubmed: 28197643
Am J Epidemiol. 2013 Mar 1;177(5):443-52
pubmed: 23364879
Arch Osteoporos. 2011;6:59-155
pubmed: 22886101
J Bone Miner Res. 2000 Jun;15(6):993-1000
pubmed: 10841167
Arch Osteoporos. 2013;8:136
pubmed: 24113837
Calcif Tissue Int. 1993 Jun;52(6):425-33
pubmed: 8369989

Auteurs

Alexander Engels (A)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical-Centre Hamburg-Eppendorf, Hamburg, Germany.

Katrin C Reber (KC)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical-Centre Hamburg-Eppendorf, Hamburg, Germany.

Ivonne Lindlbauer (I)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical-Centre Hamburg-Eppendorf, Hamburg, Germany.

Kilian Rapp (K)

Department of Clinical Gerontology and Rehabilitation, Robert-Bosch-Hospital, Stuttgart, Germany.

Gisela Büchele (G)

Department of Epidemiology and Medical Biometry, University of Ulm, Germany.

Jochen Klenk (J)

Department of Epidemiology and Medical Biometry, University of Ulm, Germany.

Andreas Meid (A)

Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.

Clemens Becker (C)

Department of Clinical Gerontology and Rehabilitation, Robert-Bosch-Hospital, Stuttgart, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical-Centre Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH